Abstract 3793: Advancing GPC3-positive solid tumor therapy with AZD9793, a novel CD8-guided T cell engager with potent pre-clinical efficacy and superior therapeutic index over GPC3 x CD3 formats
Year: 2025
Type: conference-abstract
Source: Cancer Research
Authors: Cristina Bergamaschi, Cerys Lovatt, Upneet K. Sokhi, Christine Youn, Cathryn R. Kelton, Eric Chang, Andrew Yang, Anna Huntley, Eddie Chen, Dimitris Karamitros, Eric Tu, Neil Mody, Bharat Burman, Sterling Payne, Harini Shandilya, Hanzhi Zhang, Richard Stebbings, Christopher Lloyd, Francisca Wollerton, Yariv Mazor, Simon Dovedi, Frederick W. Goldberg, Saso Cemerski, Mark Cobbold, Corinne Cayatte
Institutions: AstraZeneca (United States), AstraZeneca (United Kingdom)
Language: English
Subfield: Radiology, Nuclear Medicine and Imaging
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4409625285